AstraZeneca Plc

In the latest sign of the deepening economic crisis, more people are considering cutting back on their mental-health therapy, even as they become more stressed. Across the country, psychiatrists and psychologists say they are seeing an increasing...

MONTGOMERY, Ala. (AP) _ The state of Alabama has settled Medicaid drug pricing lawsuits it filed against prescription drug manufacturer Bristol-Myers Squibb and four other companies, a lawyer representing the state confirmed Friday. Bristol-Myers...

Eli Lilly & Co.'s antidepressant Cymbalta and AstraZeneca PLC's antipsychotic Seroquel are among 20 drugs cited by U.S. regulators in their first quarterly list of medicines under investigation for potential safety problems. The list, posted Friday on...

Micromet Inc.'s experimental cancer treatment shrank tumors in people with non-Hodgkin's lymphoma in a study that might lead to a new approach in tackling malignant diseases. The medicine, called blinatumomab, caused complete or partial tumor...

Continuing to expand its portfolio of drugs to reduce the risk of heart disease, Abbott Laboratories said Thursday it has signed an agreement with AstraZeneca PLC to co-promote the British drug giant's cholesterol-lowering drug Crestor in the U.S....

The strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth is finally starting to betray it. Beginning in just a few weeks, and continuing over the next several years, some of the biggest-selling and most...

Monday: -- Earnings: Altera Corp.; American Express Co.; Canadian National Railway Co.; Equifax Inc.; Halliburton Co.; Hasbro Inc.; Merck & Co.; Schering-Plough Corp.; Texas Instruments Inc. Tuesday: -- Earnings: Ace Ltd.; Amazon.com Inc.; AT&T Inc.;...

Q: What does the future hold for my CVS Corp. shares? -- K.T., via the Internet A: The future looks bright in a rapidly consolidating drugstore industry in which it is a leader. But it is a fiercely competitive field. CVS, with more than 6,000 stores,...

Three senior researchers at the center of a controversy at the National Institutes of Health over moonlighting for the pharmaceutical industry are leaving the government, officials said. The departures come at a time when the NIH is implementing...

Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis shows. The review of leading cholesterol drugs taken by millions...

For 15 million Americans, it is a daily ritual: gulping down a pill to reduce cholesterol. They do it because their doctors tell them to. Their doctors, in turn, rely on recommendations from the National Institutes of Health and its scientists, such as...

Wall Street stock swooned today after Federal Reserve Chairman Alan Greenspan expressed concerns about the chronic and growing U.S. trade deficit and its impact on the value of the U.S. dollar and interest rates. The Dow Jones industrial average lost...